ImmuCell - 24 Year Stock Price History | ICCC

Historical daily share price chart and data for ImmuCell since 1995 adjusted for splits. The latest closing stock price for ImmuCell as of September 17, 2019 is 5.45.
  • The all-time high ImmuCell stock closing price was 11.05 on July 30, 2015.
  • The ImmuCell 52-week high stock price is 9.30, which is 70.6% above the current share price.
  • The ImmuCell 52-week low stock price is 5.15, which is 5.5% below the current share price.
  • The average ImmuCell stock price for the last 52 weeks is 6.85.
ImmuCell Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 6.4827 7.0400 8.0900 5.1500 5.4500 -22.66%
2018 7.3511 8.2700 9.0300 6.4000 7.0465 -19.84%
2017 6.6063 5.9500 9.2300 5.2600 8.7900 47.73%
2016 6.6989 7.4300 8.2100 4.9000 5.9500 -21.09%
2015 7.1161 5.1200 11.0500 5.0200 7.5400 55.14%
2014 4.5186 4.2500 5.4500 3.4400 4.8600 13.84%
2013 3.9178 4.0000 4.9400 3.2800 4.2690 6.72%
2012 5.1370 4.8000 6.7500 3.7840 4.0001 -13.98%
2011 4.9931 3.2000 8.3400 3.0200 4.6500 45.31%
2010 3.4420 3.6500 4.3900 2.7100 3.2001 -13.74%
2009 2.5857 1.6600 4.2299 1.3800 3.7100 123.48%
2008 2.9930 3.5000 4.0000 1.6500 1.6601 -53.24%
2007 4.8873 5.9800 6.2300 3.2700 3.5500 -40.34%
2006 5.4601 5.1024 7.1500 4.5700 5.9500 13.33%
2005 4.7395 6.6560 6.6560 3.9100 5.2500 -26.68%
2004 4.3999 4.0300 9.3900 3.7000 7.1600 85.06%
2003 2.5525 1.7410 4.0800 1.7410 3.8690 130.30%
2002 2.5544 3.6000 3.6500 1.6000 1.6800 -53.97%
2001 2.8008 1.7500 4.7400 1.7500 3.6500 133.53%
2000 3.3696 2.5630 8.5000 1.5000 1.5630 -34.19%
1999 1.4813 1.2500 2.5000 1.0630 2.3750 90.00%
1998 1.9586 2.5000 2.6250 1.1250 1.2500 -49.37%
1997 2.5893 2.3750 3.2500 2.0630 2.4690 3.74%
1996 3.1341 2.3800 5.5000 2.0600 2.3800 -2.38%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.041B $0.011B
ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 28.00
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Boston Scientific (BSX) United States $58.240B 28.25
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
ResMed (RMD) United States $18.992B 36.22
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
NuVasive (NUVA) United States $3.380B 26.95
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Omeros (OMER) United States $0.915B 0.00
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Meridian Bioscience (VIVO) United States $0.422B 13.16
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.088B 20.72
MRI Interventions (MRIC) United States $0.065B 0.00
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Myomo (MYO) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00